Publications by the researcher in collaboration with Isabel González Álvarez (16)

2024

  1. In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

    Pharmaceutics, Vol. 16, Núm. 3

  2. Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole

    Pharmaceutics, Vol. 16, Núm. 5

2022

  1. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen

    International Journal of Pharmaceutics, Vol. 614

2021

  1. Nuevos hidrogeles para favorecer la cicatrización

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 175-176

2020

  1. Candesartan cilexetil in vitro–in vivo correlation: Predictive dissolution as a development tool

    Pharmaceutics, Vol. 12, Núm. 7, pp. 1-21

  2. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-30

2019

  1. Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 136, pp. 174-183

  2. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease

    Molecular Pharmaceutics, Vol. 16, Núm. 6, pp. 2418-2429

2018

  1. Ionic Hydrogel Based on Chitosan Cross-Linked with 6-Phosphogluconic Trisodium Salt as a Drug Delivery System

    Biomacromolecules, Vol. 19, Núm. 4, pp. 1294-1304

  2. Long-circulating hyaluronan-based nanohydrogels as carriers of hydrophobic drugs

    Pharmaceutics, Vol. 10, Núm. 4

  3. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment

    Journal of Controlled Release, Vol. 281, pp. 58-69

2015

  1. Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers

    Journal of Pharmacological and Toxicological Methods, Vol. 71, pp. 21-32

2011

  1. Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model

    European Journal of Pharmaceutical Sciences, Vol. 42, Núm. 3, pp. 290-299

2009

  1. Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting

    European Journal of Pharmaceutical Sciences, Vol. 36, Núm. 1, pp. 11-19

2008

  1. Correlation Between In Vitro, In Situ, and In Vivo Models

    Biosimulation in Drug Development (Wiley-VCH Verlag GmbH & Co. KGaA), pp. 87-113

  2. Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy

    Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, Vol. 366, Núm. 1880, pp. 3599-3617